Patients with hyperglycemia who do not have contraindications to orlistat and meet the indications for orlistat can be treated with orlistat.
Orlistat is a gastrointestinal lipase inhibitor, can inhibit the absorption of triglycerides, can be used in the long-term treatment of obese or overweight patients. children under 18 years of age, pregnant and lactating women, organic obesity, allergy to the drug and other groups of people prohibited the use of this drug treatment.
Therefore, patients with hyperglycemia who do not have contraindications to Orlistat and meet the indications for Orlistat can take Orlistat for treatment. It should be noted that after the use of the drug may occur such adverse reactions as fatty stools, increased frequency of defecation, increased frequency of bowel movements, rectal discomfort, upper respiratory tract infections.
Any signs and symptoms of hepatic dysfunction (e.g., decreased appetite, itching, jaundice, dark urine, light-colored stools, right upper quadrant pain) occur after taking orlistat. When any of the preceding symptoms occur, orlistat and other suspected drugs should be discontinued immediately and liver function should be tested.
Patients with hyperglycemia who require treatment with orlistat should use the medication under the supervision of a physician.